GLP-1 side effects by week: a timeline of what to expect

Introduction

GLP-1 side effects do not follow one exact week-by-week schedule. Nausea, vomiting, diarrhea, constipation, abdominal discomfort, and appetite changes can appear after treatment starts or after a dose increase, while the timing and severity vary by product and person. This timeline explains what to log during the first weeks and what symptoms should prompt a call to your provider.

Weeks 1 and 2: establish your baseline

During the first one or two weeks, record the dose, time, appetite, meals, fluids, bowel movements, energy, and symptoms. The goal is not to predict exactly what will happen. It is to create a baseline that shows your response before the first planned escalation.

Common symptoms listed in FDA prescribing information include nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite. A symptom can be mild and temporary, but repeated vomiting or inability to maintain hydration needs medical attention.

Weeks 3 and 4: look for trends, not a perfect pattern

By weeks three and four, some people notice that early digestive symptoms are less intense, while others still have symptoms or notice changes later in the dosing cycle. Do not assume that a symptom is caused by the medicine without considering food, fluids, illness, stress, other medicines, and changes in blood glucose.

Use a consistent severity scale and add a short note about what happened. A provider can use that timeline to decide whether to continue escalation, delay it, or evaluate another cause.

Dose-increase weeks: expect the pattern to change

Many GLP-1 products use gradual dose escalation. A dose increase can be followed by new or stronger digestive symptoms, but the label for your medicine determines the schedule and what to do if a dose is not tolerated. Never increase or reduce your dose to manage a symptom without your prescriber’s direction.

Track the first several days after an increase separately from the days before it. Include symptoms, food and fluid intake, sleep, and any medicines used for symptom relief. This makes a dose-related pattern easier to discuss.

Months 2 and 3: compare dose steps

After the first month, compare each dose step by symptom, appetite, weight trend, hydration, and daily function. A lower symptom score is useful, but so is knowing whether you can eat and drink adequately, work normally, exercise safely, and follow the treatment plan.

Side effects that are severe, persistent, or getting worse are not a reason to wait for the next scheduled appointment. Contact your healthcare provider. Seek urgent care for severe abdominal pain, signs of dehydration, trouble breathing, facial swelling, or other serious symptoms.

Long-term tracking shows what your provider needs to know

Once you reach a maintenance dose, continue recording meaningful changes. Symptoms can recur after interruptions, formulation changes, or a new dose. Keep your medication list current and bring your record to appointments, especially if you are switching medicines or planning a procedure.

Track your timeline with Shotsy

Shotsy places dose dates, side-effect ratings, weight, appetite, hydration, and notes on one timeline. It cannot diagnose a symptom or predict your exact medication level, but it can help you show your healthcare provider what changed and when.

Conclusion

The most accurate GLP-1 side-effect timeline is your own record, interpreted with the product label and clinical guidance. Track symptoms in weeks 1 and 2, compare trends in weeks 3 and 4, pay close attention after dose increases, and contact your provider when symptoms are severe, persistent, or concerning.

For related reading, see the GLP‑1 side-effects overview, nausea guide, and first-month guide.